PGIM Jennison Health Sciences R (PJHRX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD

36.06

-0.14 (-0.39%)

At close: Sep 4, 2026

Fund Assets	1.50B
Expense Ratio	1.48%
Min. Investment	$1,000
Turnover	81.00%
Dividend (ttm)	5.00
Dividend Yield	13.87%
Dividend Growth	-3.85%
Payout Frequency	Annual
Ex-Dividend Date	Dec 19, 2025

Previous Close	36.20
YTD Return	11.88%
1-Year Return	35.01%
5-Year Return	46.47%
52-Week Low	29.11
52-Week High	38.14
Beta (5Y)	0.93
Holdings	54
Inception Date	Feb 3, 2012

About PJHRX

The PGIM Jennison Health Sciences Fund is a mutual fund focused on achieving long-term capital appreciation by predominantly investing in companies within the healthcare, biotech, and pharmaceutical sectors. This fund targets equity-related securities of U.S. firms involved in industries such as hospitals, health insurance providers, pharmaceutical companies, and medical equipment manufacturers. By concentrating on these sectors, the fund provides a strategic investment opportunity for those interested in the healthcare and biotechnology industries. The fund's high-conviction approach is managed by experienced healthcare specialists, making it a notable player in the financial market for investors seeking exposure to these rapidly evolving sectors.

Fund Family PGIM

Category Health

Performance Rating Above Average

Risk Rating Average

Stock Exchange NASDAQ

Ticker Symbol PJHRX

Share Class Class R

Index S&P Composite 1500 Health Care TR

Performance

PJHRX had a total return of 35.01% in the past year, including dividends. Since the fund's inception, the average annual return has been 13.70%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
PHLQX	Class R6	0.80%
PHSZX	Class Z	0.88%
PHLAX	Class A	1.15%
PHLCX	Class C	1.97%

Top 10 Holdings

59.46% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	17.18%
Prudential Govt Money Mkt Fd	n/a	10.19%
Merck & Co., Inc.	MRK	6.33%
UnitedHealth Group Incorporated	UNH	6.09%
Thermo Fisher Scientific Inc.	TMO	4.61%
Vertex Pharmaceuticals Incorporated	VRTX	3.42%
CVS Health Corporation	CVS	3.16%
Danaher Corporation	DHR	3.12%
argenx SE	ARGX	2.97%
Roivant Sciences Ltd.	ROIV	2.38%

View More Holdings

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 19, 2025	$5.00136	Dec 19, 2025
Dec 20, 2024	$5.20167	Dec 20, 2024
Dec 20, 2023	$1.91322	Dec 20, 2023
Dec 20, 2022	$0.61624	Dec 20, 2022
Dec 20, 2021	$14.02528	Dec 20, 2021
Dec 20, 2019	$1.43164	Dec 20, 2019

Full Dividend History